TY - JOUR
T1 - Significant reduction of peripapillary choroidal thickness in patients with unilateral branch retinal vein occlusion
AU - Kang, Hae Min
AU - Choi, Jeong Hoon
AU - Koh, Hyoung Jun
AU - Lee, Christopher Seungkyu
AU - Lee, Sung Chul
N1 - Publisher Copyright:
© 2018 Lippincott Williams and Wilkins. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Purpose: To evaluate changes in peripapillary choroidal thickness in patients with branch retinal vein occlusion (BRVO) over 12 months, using spectral-domain optical coherence tomography with enhanced depth imaging. Methods: This retrospective, interventional case series included 20 treatment-naive patients with unilateral BRVO with at least 12 months follow-up. The peripapillary choroidal thickness was measured over 12 months. Results: In BRVO-affected eyes, the mean peripapillary choroidal thickness was 213.5 ± 51.7 μm (126.1-326.9 μm) at baseline and 129.6 ± 39.3 μm (65.9-197.1 μm) at 12 months. In nonaffected contralateral eyes, the mean peripapillary choroidal thickness was 194.1 ± 39.8 μm (158.5-238.3 μm) at baseline and 156.6 ± 56.2 μm (125.9-213.9 μm) at 12 months. The mean peripapillary choroidal thickness decreased significantly over 12 months in both BRVO-affected and nonaffected eyes (P < 0.001, both eyes). Although the mean peripapillary choroidal thickness was not significantly different between groups at baseline (P = 0.472), it was significantly lower in BRVO-affected eyes than in nonaffected eyes at 12 months (P = 0.036). Conclusion: Peripapillary choroidal thickness decreased significantly over 12 months in BRVO-affected eyes and nonaffected eyes in patients with unilateral BRVO.
AB - Purpose: To evaluate changes in peripapillary choroidal thickness in patients with branch retinal vein occlusion (BRVO) over 12 months, using spectral-domain optical coherence tomography with enhanced depth imaging. Methods: This retrospective, interventional case series included 20 treatment-naive patients with unilateral BRVO with at least 12 months follow-up. The peripapillary choroidal thickness was measured over 12 months. Results: In BRVO-affected eyes, the mean peripapillary choroidal thickness was 213.5 ± 51.7 μm (126.1-326.9 μm) at baseline and 129.6 ± 39.3 μm (65.9-197.1 μm) at 12 months. In nonaffected contralateral eyes, the mean peripapillary choroidal thickness was 194.1 ± 39.8 μm (158.5-238.3 μm) at baseline and 156.6 ± 56.2 μm (125.9-213.9 μm) at 12 months. The mean peripapillary choroidal thickness decreased significantly over 12 months in both BRVO-affected and nonaffected eyes (P < 0.001, both eyes). Although the mean peripapillary choroidal thickness was not significantly different between groups at baseline (P = 0.472), it was significantly lower in BRVO-affected eyes than in nonaffected eyes at 12 months (P = 0.036). Conclusion: Peripapillary choroidal thickness decreased significantly over 12 months in BRVO-affected eyes and nonaffected eyes in patients with unilateral BRVO.
UR - http://www.scopus.com/inward/record.url?scp=85009753469&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85009753469&partnerID=8YFLogxK
U2 - 10.1097/IAE.0000000000001495
DO - 10.1097/IAE.0000000000001495
M3 - Article
C2 - 28098732
AN - SCOPUS:85009753469
SN - 0275-004X
VL - 38
SP - 72
EP - 78
JO - Retina
JF - Retina
IS - 1
ER -